ArticleInternational orthopaedics2026
Patient selection refines total hip arthroplasty free survival after hip arthroscopy: an eighteen year, one thousand and fifty one hip cohort study.
Article in International orthopaedics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo determine whether improvement in THA-free survival across an 18-year hip arthroscopy series is attributable to progressive exclusion of high-risk patient profiles or to era-specific technical advances, and to identify the radiological selection thresholds most strongly associated with this improvement.
methodsRetrospective analysis of a prospectively maintained single-surgeon database. A consecutive series of 1,051 hips operated on for FAI (2007-2025; Tönnis grades 0 to 2) was stratified into four surgical eras. The primary outcome was THA conversion. THA-free survival was estimated by the Kaplan-Meier method; predictors of conversion were identified by multivariable Cox proportional hazards regression.
resultsEighty-three hips (7.9%) underwent THA conversion over a median follow-up of 53.6 months (5,939 patient-years). Five-year THA-free survival was 91.4% (95% CI 89.3-93.1%) overall and differed significantly across eras (log-rank p < 0.0001). Era II (2012-2015) had the lowest five-year survival (83.3%; 95% CI: 75.5-86.1%), corresponding to the peak prevalence of Tönnis grade ≥ 2 (29.5%) in the entire series. Progressive changes in radiological selection criteria were accompanied by a reduction in severe ALAD lesions identified intraoperatively. The prevalence of Tönnis grade ≥ 2 declined from 29.5% to 10.0% across eras. On multivariable analysis, ALAD grade (HR 2.59; 95% CI 1.58-4.27; p < 0.001), Tönnis grade (HR 2.13; 1.24-3.66; p = 0.006) and age (HR 1.06/year; p < 0.001) were independent predictors of THA conversion; era hazard ratios were non-significant after adjustment for these variables (p > 0.19). The five-year estimate for Era IV (95.9%) should be interpreted with caution given the limited follow-up in this cohort (median 30.8 months). Apparent C-index: 0.911 (95% CI 0.882-0.940); no internal validation was performed.
conclusionImprovement in THA-free survival over 18 years was closely associated with the progressive reduction in the proportion of operated patients with Tönnis grade ≥ 2. Although technical evolution occurred concurrently, era effects were substantially attenuated after adjustment for patient selection variables. Tönnis grade functions as the primary pre-operative selection variable; ALAD grade, identified intraoperatively, had the highest adjusted hazard ratio for THA conversion and reflects the consequences of pre-operative selection. These findings support the importance of pre-operative radiological selection-particularly Tönnis grade-when interpreting THA conversion rates across institutions and historical surgical series.
Indexed as
Identifiers
42429932What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.